From Raynaud Phenomenon to Systemic Sclerosis in COVID-19: A Case Report.
Adv Skin Wound Care
; 35(2): 123-124, 2022 Feb 01.
Article
in English
| MEDLINE | ID: covidwho-1462505
ABSTRACT
ABSTRACT In 2019, the novel SARS-CoV-2 infection emerged, causing the disease called COVID-19, which primarily affects the respiratory tract and lung at alveolar and interstitial levels. Systemic sclerosis (SSc) is an autoimmune connective disease characterized by vascular abnormalities and diffuse and progressive fibrosis of the skin and internal organs. Raynaud phenomenon (RP) occurs in virtually all patients affected by SSc and, in most cases, is an onset symptom of the disease; that is, RP may appear several years before overt illness. Although the exact pathophysiologic pathways leading to RP and SSc are still unknown, several infectious agents, especially viruses, have been suggested as possible triggering factors. Here, the authors describe the first case of RP secondary to SSc following SARS-CoV-2 infection.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Raynaud Disease
/
Scleroderma, Systemic
/
COVID-19
Type of study:
Case report
/
Diagnostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Adv Skin Wound Care
Journal subject:
Nursing
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS